Savigny L'Evescault, France

Jean-Marie Berjeaud

This inventor holds 2 USPTO granted patents. Top assignee: Rhodia Chimie. Active years: 2005-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Marie Berjeaud. Retrieved from https://idiyas.com/inventor/jean-marie-berjeaud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Marie Berjeaud

Introduction

Jean-Marie Berjeaud is a notable inventor based in Savigny L'Evescault, France. He has made significant contributions to the field of biotechnology, particularly in the development of bacteriocins. With a total of 2 patents, Berjeaud's work focuses on enhancing food safety through innovative solutions.

Latest Patents

Berjeaud's latest patents include an isolated polypeptide known as Sakacin G, which is derived from a specific strain. This invention involves a nucleic acid molecule that encodes for the bacteriocin and highlights its use as an active agent against pathogenic and undesirable flora in food products. The anti-listeria bacteriocin is particularly noteworthy for its potential to improve food safety.

Career Highlights

Jean-Marie Berjeaud is associated with Rhodia Chimie, a company known for its advancements in chemical solutions. His work at Rhodia Chimie has allowed him to explore innovative applications of biotechnology in food safety.

Collaborations

Some of Berjeaud's notable coworkers include Christophe Fremaux and Yves Cenatiempo. Their collaboration has likely contributed to the success of his innovative projects.

Conclusion

Jean-Marie Berjeaud's contributions to biotechnology through his patents demonstrate his commitment to improving food safety. His work continues to influence the industry and showcases the importance of innovation in addressing public health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…